Oral & Respiratory Status of Retarded/Disabled Persons
口服
基本信息
- 批准号:6887549
- 负责人:
- 金额:$ 22.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Respiratory tract infections are the primary causes of death in institutionalized mentally retarded and developmental disabled (MRDD) persons. Aspiration of contaminated oral secretions is a major cause of respiratory infections and oral colonization by pathogenic bacteria resulting from inadequate oral hygiene has been shown to be routine in other high-risk populations. MRDD patients have similar risk factors for oral respiratory pathogen colonization as critically ill and nursing home patients, including dry mouth and poor oral hygiene. Poor oral status may be common in institutionalized MRDD patients, a significant health disparity, and it is not known if their oral cavities become colonized with pathogenic respiratory organisms. We thus propose to conduct exploratory research to fill this gap in knowledge, evaluate measures and methodology, and provide pilot data for a properly powered clinical trial. This developmental/exploratory research seeks to answer the following questions in institutionalized MRDD patients: 1. What is the oral status of institutionalized MRDD patients? 2. What is the prevalence of oral respiratory pathogen colonization? 3. What species and quantity of respiratory pathogens colonize the oral cavity in this population? 4. Is poor oral status associated with oral respiratory pathogen colonization? 5. Is poor oral status and respiratory pathogen colonization associated with respiratory infection? We will conduct an exploratory study of 220 institutionalized MRDD patients at four facilities. Oral examinations and sample collection will be performed at baseline and then monthly until the end of month six. PCR analysis will be performed on all teeth and tongue samples collected from these 200 subjects. We will also monitor the incidence of respiratory tract infections over the 6-month period. The primary outcomes will be prevalence of respiratory pathogen colonization, and the types and quantities of pathogens as determined by PCR analysis of microbiological samples. Explanatory variables will include Plaque, Gingivitis, and Oral Hygiene Indices, co-morbidities, and professional and routine oral care. Secondary outcomes will be the association of oral status and respiratory pathogen colonization with respiratory tract infections including pneumonia over the 6-month reporting period. The proposed study will test measures and methodology and will provide pilot data for sample size estimation for a full clinical trial.
描述(由申请人提供):呼吸道感染是制度化弱智和发育障碍(MRDD)患者的主要死亡原因。吸入受污染的口腔分泌物是呼吸道感染的主要原因,而口腔卫生不良导致的病原菌在口腔定植已被证明是其他高危人群的常见现象。MRDD患者的口腔呼吸道病原体定植风险因素与重症患者和疗养院患者相似,包括口干和口腔卫生不良。在住院的MRDD患者中,口腔状况不佳可能很常见,这是一个显著的健康差异,并且尚不清楚他们的口腔是否被致病性呼吸道微生物定植。因此,我们建议进行探索性研究,以填补这一知识空白,评估措施和方法,并提供适当的动力临床试验的试点数据。这项发展性/探索性研究旨在回答以下问题,在制度化的MRDD患者:1。住院MRDD患者的口腔状况如何?2.口腔呼吸道病原体定植的患病率是多少?3.该人群口腔中定植的呼吸道病原体的种类和数量是多少?4.口腔状况不佳与口腔呼吸道病原体定植相关吗?5.口腔状况不佳和呼吸道病原体定植与呼吸道感染相关吗?我们将在四个机构对220名住院MRDD患者进行探索性研究。将在基线时进行口腔检查和样本采集,然后每月进行一次,直至第6个月结束。将对从这200名受试者中采集的所有牙齿和舌头样本进行PCR分析。我们亦会在6个月期间监察呼吸道感染的发病率。主要结局将是呼吸道病原体定植的患病率,以及通过微生物样本的PCR分析确定的病原体类型和数量。解释变量将包括牙菌斑、牙龈炎和口腔卫生指数、共病以及专业和常规口腔护理。次要结局将是6个月报告期内口腔状况和呼吸道病原体定植与呼吸道感染(包括肺炎)的相关性。拟议的研究将测试措施和方法,并将为完整临床试验的样本量估计提供试点数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATHERINE J BINKLEY其他文献
CATHERINE J BINKLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATHERINE J BINKLEY', 18)}}的其他基金
Oral Health Intervention for Intellectually/Developmentally Disabled Persons
智力/发育障碍人士的口腔健康干预
- 批准号:
8211350 - 财政年份:2011
- 资助金额:
$ 22.05万 - 项目类别:
Oral Health Intervention for Intellectually/Developmentally Disabled Persons
智力/发育障碍人士的口腔健康干预
- 批准号:
8333308 - 财政年份:2011
- 资助金额:
$ 22.05万 - 项目类别:
Oral H. pylori Prevalence in Intellectually/Developmentally Disabled Adults
智力/发育障碍成人中口腔幽门螺杆菌的患病率
- 批准号:
7470333 - 财政年份:2008
- 资助金额:
$ 22.05万 - 项目类别:
Oral H. pylori Prevalence in Intellectually/Developmentally Disabled Adults
智力/发育障碍成人中口腔幽门螺杆菌的患病率
- 批准号:
7645788 - 财政年份:2008
- 资助金额:
$ 22.05万 - 项目类别:
Oral Chlorhexidine effect on ICU mortality and ventilator-associated pneumonia
口服洗必太对 ICU 死亡率和呼吸机相关性肺炎的影响
- 批准号:
7467389 - 财政年份:2007
- 资助金额:
$ 22.05万 - 项目类别:
Oral Chlorhexidine effect on ICU mortality and ventilator-associated pneumonia
口服洗必太对 ICU 死亡率和呼吸机相关性肺炎的影响
- 批准号:
7313219 - 财政年份:2007
- 资助金额:
$ 22.05万 - 项目类别:
Chlorhexidine and Pneumonia in Nursing Home Residents
疗养院居民的洗必太和肺炎
- 批准号:
7020079 - 财政年份:2005
- 资助金额:
$ 22.05万 - 项目类别:
Chlorhexidine and Pneumonia in Nursing Home Residents
疗养院居民的洗必太和肺炎
- 批准号:
6869139 - 财政年份:2005
- 资助金额:
$ 22.05万 - 项目类别:
Chlorhexidine and Pneumonia in Nursing Home Residents
疗养院居民的洗必太和肺炎
- 批准号:
7364599 - 财政年份:2005
- 资助金额:
$ 22.05万 - 项目类别:
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 22.05万 - 项目类别:
睡眠時無呼吸症と睡眠時ブラキシズムのcomorbidityを成立させる病態生理機構の解明
阐明睡眠呼吸暂停和睡眠磨牙症并存的病理生理机制
- 批准号:
24K02631 - 财政年份:2024
- 资助金额:
$ 22.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
- 批准号:
10838849 - 财政年份:2024
- 资助金额:
$ 22.05万 - 项目类别:
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 22.05万 - 项目类别:
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 22.05万 - 项目类别:
Multimorbidity in Children and Youth Across the Life-course (MY LIFE): A Long-term Follow-up
儿童和青少年一生中的多重疾病(我的一生):长期随访
- 批准号:
483695 - 财政年份:2023
- 资助金额:
$ 22.05万 - 项目类别:
Operating Grants
ARISTOTELES - Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS
亚里士多德 - 应用人工智能定义临床轨迹,以实现个性化预测以及合并症和多发病模式的早期检测
- 批准号:
10103153 - 财政年份:2023
- 资助金额:
$ 22.05万 - 项目类别:
EU-Funded
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 22.05万 - 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
- 批准号:
10555723 - 财政年份:2023
- 资助金额:
$ 22.05万 - 项目类别:
Simulating the Spread and Control of Multiple MDROs Across a Network of Different Nursing Homes
模拟多个 MDRO 在不同疗养院网络中的传播和控制
- 批准号:
10549492 - 财政年份:2023
- 资助金额:
$ 22.05万 - 项目类别: